Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AdAlta Ltd (ASX:1AD)'s Tim Oldham gives investors the lowdown on a pre-clinical program for the inhaled version of its AD-214 drug candidate. It comes after...
AdAlta Ltd (ASX:1AD) has expanded its global patent portfolio with the grant of the first Indian patent relating to its lead program, AD-214, from the...
If we set aside the COVID-19 pandemic for a second, non-communicable diseases are still the big game for clinical-stage biotechs. These diseases, which...
Adalta (AdAlta Ltd (ASX:1AD)) Chief Executive Officer & Managing Director, Dr Tim Oldham joins Proactive's Katie Pilbeam after achieving...
“We are very pleased to share the proof of principle data that so excited us about the potential of this collaboration. We look forward to...